EVgo Rises 5.71% But Bearish Signals Dominate Outlook

Market Snapshot

Headline Takeaway: Despite a recent 5.71% price rise, EVgo shows a weak technical outlook with bearish indicators dominating. Investors are advised to tread carefully.

News Highlights

EVgo shares are currently trading higher, but the recent news environment is dominated by legal issues at Compass Diversified Holdings (CODI), including multiple class-action lawsuits. These developments may indirectly affect market sentiment around EVgo, especially given the general volatility in the sector.

• CODI Lawsuits: Compass Diversified faces multiple class-action lawsuits over potential securities violations. Investors are advised to file claims by July 8, 2025, with some law firms representing shareholders.
• Diversified Healthcare Trust Outlook: S&P Global Ratings upgraded Diversified Healthcare Trust (DHC) to positive from negative, citing improved debt management and operating performance. This reflects positively on the broader diversified sector but is not directly tied to EVgo.
• Chinese Pharmaceutical Update: CSPC, a major player in China's pharmaceutical industry, is highlighted for its diversified pipeline and flagship drug NBP used in stroke treatment. While not directly related to EVgo, it underscores the broader appeal of diversified models in key sectors.

Analyst Views & Fundamentals

Analysts remain split on EVgo, with a simple average rating of 5.00 and a performance-weighted rating of 2.75, indicating low confidence in their recommendations. This lack of consensus contrasts sharply with the recent 5.71% price rise, suggesting a mismatch between expectations and performance.

Key Fundamentals and Internal Diagnostic Scores

• Net Cash Flow from Operating Activities per Share (YoY growth rate %): -435.30 – internal diagnostic score: 2
• Equity Multiplier: 6.77 – internal diagnostic score: 2
• Current Liabilities / Total Liabilities (%): 24.59% – internal diagnostic score: 2
• Profit-MV: 0.48 – internal diagnostic score: 2
• Non-Current Liabilities / Total Liabilities (%): 75.41% – internal diagnostic score: 3
• Current Assets Turnover Ratio: 1.08 – internal diagnostic score: 0
• Cash-UP: -5.26% – internal diagnostic score: 2
• Long-Term Debt to Working Capital Ratio (%): 2.70% – internal diagnostic score: 2
• Asset-MV: -5.08% – internal diagnostic score: 2

Money-Flow Trends

EVgo has seen positive overall money flows, with large and extra-large investors leading the way. The block inflow ratio is 50.63%, suggesting institutional confidence, while retail sentiment is mixed. Small investors showed a negative trend, which could point to hesitation in the broader retail market.

Despite the bearish technical signals, the fund-flow score of 7.97 (on a 0-10 scale) is considered “good,” indicating strong inflows from major players in the market.

Key Technical Signals

EVgo’s technical outlook is weak, with more bearish signals than bullish ones over the last 5 days. Here are the key indicators and their internal diagnostic scores (0-10):

• MACD Golden Cross: internal diagnostic score: 7.75 (neutral rise, positive momentum)
• Long Upper Shadow: internal diagnostic score: 1 (neutral bias, bearish potential)

• Bullish Engulfing: internal diagnostic score: 1 (biased bearish, weak signal)
• Marubozu White: internal diagnostic score: 1 (biased bearish, weak signal)

Recent chart patterns include two instances of Long Upper Shadow on January 12 and 22, 2026, and a MACD Golden Cross on January 5. However, the overall trend remains weak due to the dominance of bearish signals over the last 5 days.

Conclusion

EVgo is caught between a modest price rise and overwhelmingly bearish technical signals. While large investors are stepping in, the weak technical outlook and lack of consensus among analysts suggest caution. Investors are advised to consider waiting for a pull-back before entering or adding to positions in EVgo, and to monitor upcoming earnings or major news for clearer directional clues.